INTRODUCTION
Corticosteroids are widely used for the treatment of asthma, other allergic, autoimmune and neoplastic diseases. Despite their clinical efficacy, they can induce immediate or delayed hypersensitivity reactions [1, 2] . Immediate allergic reactions such as generalized coetaneous eruption (urticaria), severe respiratory distress or collapse are less frequent but may also occur [1] . Allergic reactions after parenteral administration of corticosteroids have rarely been reported in literature and most of them were isolated cases [2, 3] . Only a few reports have shown evidence of IgE antibodies to culprit corticosteroids [4, 5, 6] .
Because of their low molecular mass, corticosteroids probably act as haptens. The allergic reactions may be caused by the steroid molecule itself, its ester or the excipients in preparation [1] .
Corticosteroids have been classified according to Coopman [7] in four reactivity groups (A, B, C and D) based on their structural and chemical characteristics. Different patterns of cross-reactivity have been reported [8, 9] . Some authors report allergy to corticosteroids belonging to the A group of Coopman classification [1] . Others describe cross-reactivity between different succinate esters [4] or between steroids with similar chemical structure, although they belong to different groups of Coopman classification [10] .
In patients allergic to one or more corticosteroids, it is very important to establish those which patients can tolerate, because these drugs represent the most effective treatment for different diseases and sometimes they are the only possible drug to use in daily medical practice [1] .
CASE REPORT
We report a case of immediate allergic reaction induced by methylprednisolone with tolerance of other corticosteroids. A 12-year-old boy had an anaphylactic reaction within a few minutes after intravenous injection of 60 mg methylprednisolone given before operation for surgical repair of his right arm contracture as a sequel of burns, which he had tolerated one month before. Symptoms included generalized urticaria, drop in blood pressure, cold sweats, dyspnoea and wheezing (respiratory distress). After treatment with epinephrine and chloropyraminum, his symptoms were considerably reduced within one hour and completely resolved after 6 hours. Tryptase level (ImmunoCAP, Phadia, Uppsala, Sweden, cut-off >6.6 μg/l) was 35 mg/l, five times higher than the referent value, which was rapidly reversed by epinephrine.
The patient had allergic rhinitis and used intranasal steroids mometasone furoat, but had no family history of allergic disease. Six weeks later the child was referred to our department in order to study drug reactions and to determine safe alternative drugs for the future.
The child underwent prick and intradermal skin tests with the commercial preparation of methylprednisolone which were diluted in saline solution (1:10 to 1:1000), as well as with prednisolone, prednisone, hydrocortisone, budesonide, betametasone, dexamethasone and betametasone dipropionate. Saline solution and histamine dihydrochloride (0.1 mg/mL) were used as negative and positive controls, respectively.
Skin tests were performed in accordance with the general ENDA/EAACI guidelines for evaluating and diagnosing subjects with a suspicion of immediate allergic reactions to drugs [11] . In case of positive skin tests further examinations were interrupted and the child was considered allergic to that drug, as previously described. If negative, a drug provocation test (DPT) was done to confirm the diagnosis and assess cross-reactivity [12, 13] .
The patient responded positively to intradermal testing with methylprednisolone (wheal 15×25 mm) at a dilution of 1:100. Ten min after application urticarial rash appeared on his arm, face and neck, with drop in blood pressure, which required immediately the administration of epinephrine and cetirizine. Intradermal tests with other above mentioned corticosteroids, belonging to the same or to another group of the Coopman classification were negative. Skin prick and intradermal testing was negative in three control subjects.
The presence of type I hypersensitivity to methylprednisolone was assessed by a basophile activation test (Flow2CAST, Bühlman, Switzerland). Briefly, the patient's whole blood was incubated for 30 minutes with methylprednisolone (0.1 μg/mL), and the percentage of activated basophiles was thereafter determined by measuring the expression of CD63 on a flow cytometer using an appropriate monoclonal antibody. The drug induced activation in 20.2% of basophiles. Since 6.0% of basophiles were activated in the control sample, the stimulation index (the ratio between percentages of CD63 + basophiles in the test sample to that in the control sample) was 3.4.
The methylprednisolone ImmunoCAP (Phadia) was not performed because it was not available in our country.
DISCUSSION
This is the first report describing a child who experienced intraoperative anaphylaxis to methylprednisolone and six weeks later repeated the anaphylactic reaction during skin testing to the same drug. It is widely accepted that patients allergic to one corticosteroid usually shows cross-reactivity to other molecules, because they have common chemical structures [9] . French authors [14] have described cross-reactivity between methylprednisolone and hydrocortisone, two drugs which belong to the A group of corticosteroids. The patient tolerated prednisolone, the corticosteroid which belongs to group A. However, in our case, the child tolerated corticosteroids which belong to group B, C and D, but also other corticosteroids belonging to group A, according to Coopman. Thus, we did not demonstrate any cross-reactivity among different corticosteroids.
Positive skin tests and positive BAT revealed an immediate type I hypersensitivity to methylprednisolone in the case presented in this report. The lack of cross-reactivity with other corticosteroids emphasizes that the reactions were isolated to methylprednisolone.
We believe that our observation is important, because we demonstrated a relationship from the clinical point of view, with skin testing and BAT as a diagnostic tool for the diagnosis of IgE mediated allergy to corticosteroids.
